Free Trial
NYSE:DVA

DaVita (DVA) Stock Price, News & Analysis

DaVita logo
$142.43 -1.03 (-0.72%)
Closing price 07/11/2025 03:58 PM Eastern
Extended Trading
$141.51 -0.92 (-0.65%)
As of 07/11/2025 05:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About DaVita Stock (NYSE:DVA)

Key Stats

Today's Range
$141.77
$143.32
50-Day Range
$134.44
$146.77
52-Week Range
$131.76
$179.60
Volume
537,608 shs
Average Volume
812,048 shs
Market Capitalization
$10.75 billion
P/E Ratio
14.12
Dividend Yield
N/A
Price Target
$164.50
Consensus Rating
Hold

Company Overview

DaVita Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
89th Percentile Overall Score

DVA MarketRank™: 

DaVita scored higher than 89% of companies evaluated by MarketBeat, and ranked 116th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    DaVita has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 4 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    DaVita has only been the subject of 1 research reports in the past 90 days.

  • Read more about DaVita's stock forecast and price target.
  • Earnings Growth

    Earnings for DaVita are expected to grow by 18.12% in the coming year, from $10.76 to $12.71 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of DaVita is 14.12, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.85.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of DaVita is 14.12, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.26.

  • Price to Earnings Growth Ratio

    DaVita has a PEG Ratio of 0.98. PEG Ratios around 1 indicate that a company is correctly valued.

  • Price to Book Value per Share Ratio

    DaVita has a P/B Ratio of 29.49. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about DaVita's valuation and earnings.
  • Percentage of Shares Shorted

    8.48% of the float of DaVita has been sold short.
  • Short Interest Ratio / Days to Cover

    DaVita has a short interest ratio ("days to cover") of 7.2.
  • Change versus previous month

    Short interest in DaVita has recently decreased by 1.93%, indicating that investor sentiment is improving.
  • Dividend Yield

    DaVita does not currently pay a dividend.

  • Dividend Growth

    DaVita does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    8.48% of the float of DaVita has been sold short.
  • Short Interest Ratio / Days to Cover

    DaVita has a short interest ratio ("days to cover") of 7.2.
  • Change versus previous month

    Short interest in DaVita has recently decreased by 1.93%, indicating that investor sentiment is improving.
  • News Sentiment

    DaVita has a news sentiment score of 1.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for DaVita this week, compared to 11 articles on an average week.
  • Search Interest

    Only 5 people have searched for DVA on MarketBeat in the last 30 days. This is a decrease of -17% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added DaVita to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, DaVita insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.00% of the stock of DaVita is held by insiders.

  • Percentage Held by Institutions

    90.12% of the stock of DaVita is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about DaVita's insider trading history.
Receive DVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DaVita and its competitors with MarketBeat's FREE daily newsletter.

DVA Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Day in the Life: Jena, DaVita Social Worker
Buffett Stock Portfolio: Top 10 Stock Picks for 2025
See More Headlines

DVA Stock Analysis - Frequently Asked Questions

DaVita's stock was trading at $149.55 on January 1st, 2025. Since then, DVA stock has decreased by 4.8% and is now trading at $142.4330.

DaVita Inc. (NYSE:DVA) released its earnings results on Monday, May, 12th. The company reported $2.00 EPS for the quarter, beating the consensus estimate of $1.75 by $0.25. The business's quarterly revenue was up 5.0% on a year-over-year basis.
Read the conference call transcript
.

DaVita subsidiaries include these companies: Northwest Physicians Network, Purity Dialysis, Family Health Care of Central Florida, Healthcare Partners, Gambro Healthcare, Aberdeen Dialysis LLC, Accountable Kidney Care LLC, and others.

DaVita's top institutional shareholders include Wedge Capital Management L L P NC (0.36%), Stolper Co (0.06%), Abacus FCF Advisors LLC (0.05%) and Mn Services Vermogensbeheer B.V. (0.02%). Insiders that own company stock include Javier Rodriguez, Michael David Staffieri, Joel Ackerman, Kathleen Alyce Waters, James O Hearty, Charles Berg, John M Nehra, Phyllis R Yale and Barbara J Desoer.
View institutional ownership trends
.

Shares of DVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that DaVita investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), TotalEnergies (TTE) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
5/12/2025
Today
7/13/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - OUTP/HM CRE
Sub-Industry
Health Care Services
Current Symbol
NYSE:DVA
CIK
927066
Employees
76,000
Year Founded
1999

Price Target and Rating

High Price Target
$184.00
Low Price Target
$145.00
Potential Upside/Downside
+15.5%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
$10.09
Trailing P/E Ratio
14.12
Forward P/E Ratio
13.24
P/E Growth
0.98
Net Income
$936.34 million
Net Margins
6.63%
Pretax Margin
11.14%
Return on Equity
176.11%
Return on Assets
4.66%

Debt

Debt-to-Equity Ratio
23.18
Current Ratio
1.25
Quick Ratio
1.20

Sales & Book Value

Annual Sales
$12.82 billion
Price / Sales
0.84
Cash Flow
$19.12 per share
Price / Cash Flow
7.45
Book Value
$4.83 per share
Price / Book
29.49

Miscellaneous

Outstanding Shares
75,500,000
Free Float
73,990,000
Market Cap
$10.75 billion
Optionable
Optionable
Beta
1.11

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NYSE:DVA) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners